| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 437 | 316 | 25 |
| Full Text Views | 18 | 4 | 0 |
| PDF Downloads | 20 | 5 | 0 |
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1.
F J Medrano
F J Medrano
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by F J Medrano in
Current site
Google Scholar
PubMed
Search for other papers by F J Medrano in
Current site
Google Scholar
PubMed
C Cañavate
C Cañavate
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by C Cañavate in
Current site
Google Scholar
PubMed
Search for other papers by C Cañavate in
Current site
Google Scholar
PubMed
M Leal
M Leal
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by M Leal in
Current site
Google Scholar
PubMed
Search for other papers by M Leal in
Current site
Google Scholar
PubMed
C Rey
C Rey
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by C Rey in
Current site
Google Scholar
PubMed
Search for other papers by C Rey in
Current site
Google Scholar
PubMed
E Lissen
E Lissen
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by E Lissen in
Current site
Google Scholar
PubMed
Search for other papers by E Lissen in
Current site
Google Scholar
PubMed
J Alvar
J Alvar
Department of Internal Medicine, Hospital Universitario Virgen del Rocio, Seville, Spain.
Search for other papers by J Alvar in
Current site
Google Scholar
PubMed
Search for other papers by J Alvar in
Current site
Google Scholar
PubMed
To define the possible role of serology in the diagnosis and prognosis of visceral leishmaniasis (VL) in patients with human immunodeficiency virus type-1 (HIV-1) infection, the dynamics of humoral immune responses was investigated in 20 coinfected patients. Sequential sera obtained before, during, and after VL diagnosis were analyzed by an indirect immunofluorescent antibody test (IFAT), a recombinant ELISA (using the rK39 protein), and immunoblotting. During the active course of the disease, positive results were found by IFAT or ELISA in 22% of the cases and by immunoblotting in 78% of the cases. A great variability in the response was observed during the follow-up with a trend to more positive results near the time of VL diagnosis. Forty-six percent of the patients were positive by IFAT or ELISA on at least one time point before VL and 37.5% were positive during the period following treatment. These results confirm the limited usefulness of the IFAT and ELISA in the diagnosis of VL in coinfected patients and demonstrate their low ability to predict the development or the outcome of disease. In these patients, immunoblotting could be a useful tool for studying the natural course of leishmaniasis, although it has limited value for diagnosis or treatment control.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 437 | 316 | 25 |
| Full Text Views | 18 | 4 | 0 |
| PDF Downloads | 20 | 5 | 0 |